About Off-label use (extralabel use)
Off-label use means using an already approved drug differently from its approved details, that is, from the way written on the label. In its explanation of AMDUCA (the Animal Medicinal Drug Use Clarification Act of 1994), the US Food and Drug Administration (FDA) defines extralabel use as actual or intended use of a drug in a manner not in accordance with the approved labeling. A different animal species, a different disease, a different dose or route of administration, and a different withdrawal period are included here.
In the United States, AMDUCA opens a way for veterinarians to prescribe extralabel use of approved animal drugs and approved human drugs, but sets conditions. FDA explains that there must be a valid veterinarian-client-patient relationship (VCPR), that use is limited to situations where the animal's health is threatened, that production enhancement is not a purpose, that extralabel use mixed into feed is not allowed, and that use by lay persons is allowed only under veterinary supervision. It states that records are kept for 2 years or for the longer period required by federal or state law.
The United Kingdom handles the same problem as a stepwise order (the cascade). The UK Veterinary Medicines Directorate (VMD) explains that a drug authorised for the animal species and condition must be considered first, and only when there is none can the order go down to an animal drug authorised for another species or condition, then a human drug or an animal drug authorised overseas, and last a preparation made up by a veterinarian or pharmacist. Only a veterinarian registered with the Royal College of Veterinary Surgeons (RCVS) can prescribe, and owner consent and a clinical assessment are required. It states that a human drug must not be prescribed merely because it is cheaper.
The range confirmed in Korea while writing this entry is narrow. Article 42, paragraph 2 of the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) has the container, packaging and package insert state the efficacy and effect and the cautions set at product approval, and Article 43, paragraph 3 has product features stated objectively within the approved range. A provision that defines off-label use itself or sets out its conditions as steps could not be confirmed. How to substitute livestock or human drugs for a companion animal is not covered here, and administration follows a veterinarian's examination and the product instructions. This entry is an editorial draft and professional review has not been completed.
How it appears on labels
| On Korean labels | 제품 설명서의 「효능·효과」 「사용 대상 동물」란에 적힌 범위가 허가 사항이다. 그 밖의 사용을 허가 외 사용이라 부른다. (The range written in the "efficacy and effect" and "target animals" columns of the product instructions is the approved detail; use beyond it is called off-label use.) |
|---|---|
| On English labels | Overseas it is described as off-label use or extralabel use. |
| Unit / basis | Not applicable |
Which standard is it?
- FDA AMDUCA: Use not in accordance with the approved labeling is extralabel use; it is limited to when the animal's health is threatened within a veterinarian-client-patient relationship (VCPR), and use in feed and sole use by lay persons are restricted.
- FDA extralabel use guidance: The principle is that there is no approved drug of the same active ingredient, dosage form and concentration for the use, and it states that records are kept for at least 2 years.
- UK VMD cascade: An authorised animal drug first, then stepwise choices, prescription only by an RCVS-registered veterinarian, owner consent and clinical assessment, and a human drug cannot be prescribed because it is cheaper.
- Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) Articles 42 and 43: The label states the efficacy and effect and the product features within the approved range (conditions for off-label use could not be confirmed in this entry).
Common misconceptions
- Off-label use is either illegal or only dangerous → FDA and the VMD describe it as allowed in a manner under the judgment of a veterinarian who meets the conditions. However, the VMD states that the convenience of buying a human drug or its price cannot be the reason.
- An owner using a human drug or another animal's drug differently from the label falls under the same framework → FDA limits lay use of extralabel drugs to when it is under veterinary supervision, and this entry does not cover how an owner substitutes a drug.
What to check on the label
- If a veterinarian proposes a prescription that differs from the approved details, ask the reason and whether there is an approved alternative.
- Check the target animals and the range of efficacy and effect written in the product instructions.
- Always consult a veterinarian before giving an animal a human drug or a livestock drug kept at home.
Related guides
Where was this checked?
- InternationalU.S. FDA Center for Veterinary Medicine · Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) ↗
Definition of extralabel use, veterinarian and VCPR conditions, limitation to health threats, restrictions on feed and lay persons. (checked 2026-11-22)
- InternationalU.S. FDA Center for Veterinary Medicine · Ins and Outs of Extra-Label Drug Use in Animals: A Resource for Veterinarians ↗
The three elements of VCPR, the principle when there is no approved drug of the same active ingredient, records kept for 2 years. (checked 2026-11-22)
- InternationalGOV.UK Veterinary Medicines Directorate · The cascade: prescribing unauthorised medicines ↗
The order of the cascade steps, RCVS-registered veterinarians, owner consent, and a human drug not allowed because it is cheaper. (checked 2026-11-22)
- KoreaNational Law Information Center (국가법령정보센터) · Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) ↗
Article 42, paragraph 2 labeling of efficacy and effect; Article 43, paragraph 3 labeling of product features within the approved range. (checked 2026-11-22)
Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean entry is an explainer newly written from these sources, not a full translation of them. Not a diagnosis, prescription or feeding instruction. Korean edition checked 2026-11-22 · no paid partnerships.